시장보고서

상품코드

1530915

세계의 표피 성장 인자 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)

Epidermal Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

발행일: 2024년 06월 | 리서치사:

Transparency Market Research | 페이지 정보: 영문 134 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

표피 성장 인자(EGFs) 시장 - 조사 범위

TMR의 조사 보고서 '표피 성장 인자(EGFs) 세계 시장''은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해 또한 조사했습니다. 본 보고서는 2024년을 기준년, 2034년을 예측년으로 하여 2018년부터 2034년까지 세계의 표피성장인자(EGFs) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 표피 성장 인자(EGFs) 시장의 복합 연간 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서를 참조하여 표피 성장 인자(EGFs) 시장을 추측했습니다.

시장 현황
2023년 시장 매출	11억 달러
2034년 시장 매출	37억 달러
CAGR	11.3%

이 보고서는 세계 표피 성장 인자(EGFs) 시장 경쟁 구도에 대해 파악하고 있습니다. 세계의 표피성장인자(EGFs) 시장에서 사업을 전개하는 주요기업이 확인되고 각 기업은 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT는 본 보고서에 소개된 세계 표피 성장 인자(EGFs) 시장에서 기업의 속성입니다.

TMR's report on the global epidermal growth factors (EGFs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global epidermal growth factors (EGFs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global epidermal growth factors (EGFs) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the epidermal growth factors (EGFs) market.

Market Snapshot
Market Value in 2023	US$ 1.1 Bn
Market Value in 2034	US$ 3.7 Bn
CAGR	11.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global epidermal growth factors (EGFs) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global epidermal growth factors (EGFs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global epidermal growth factors (EGFs) market.

The report delves into the competitive landscape of the global epidermal growth factors (EGFs) market. Key players operating in the global epidermal growth factors (EGFs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global epidermal growth factors (EGFs) market profiled in this report.

Key Questions Answered in Global epidermal growth factors (EGFs) Market Report:

What is the sales/revenue generated by epidermal growth factors (EGFs) across all regions during the forecast period?
What are the opportunities in the global epidermal growth factors (EGFs) market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Epidermal Growth Factors (EGFs) Market - Research Objectives and Research Approach

The comprehensive report on the global epidermal growth factors (EGFs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global epidermal growth factors (EGFs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global epidermal growth factors (EGFs) market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Epidermal Growth Factors (EGFs) Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Epidermal Growth Factors (EGFs) Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Type of EGFs

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 6.3.1. TGF-alpha
- 6.3.2. Amphiregulin
- 6.3.3. Epiregulin
- 6.3.4. Betacellulin
- 6.3.5. Others
6.4. Market Attractiveness Analysis, by Type of EGFs

7. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Application

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
- 7.3.1. Skincare Products
- 7.3.2. Wound Healing
- 7.3.3. Cancer Therapy
- 7.3.4. Autoimmune Disorders
- 7.3.5. Regenerative Medicine
- 7.3.6. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by End-user

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
8.4. Market Attractiveness Analysis, by End-user

9. Global Epidermal Growth Factors (EGFs) Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Epidermal Growth Factors (EGFs) Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 10.3.1. TGF-alpha
- 10.3.2. Amphiregulin
- 10.3.3. Epiregulin
- 10.3.4. Betacellulin
- 10.3.5. Others
10.4. Market Value Forecast, by Application, 2020-2034
- 10.4.1. Skincare Products
- 10.4.2. Wound Healing
- 10.4.3. Cancer Therapy
- 10.4.4. Autoimmune Disorders
- 10.4.5. Regenerative Medicine
- 10.4.6. Others
10.5. Market Value Forecast, by End-user, 2020-2034
- 10.5.1. Hospitals
- 10.5.2. Specialty Clinics
- 10.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Type of EGFs
- 10.7.2. By Application
- 10.7.3. By End-user
- 10.7.4. By Country

11. Europe Epidermal Growth Factors (EGFs) Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 11.3.1. TGF-alpha
- 11.3.2. Amphiregulin
- 11.3.3. Epiregulin
- 11.3.4. Betacellulin
- 11.3.5. Others
11.4. Market Value Forecast, by Application, 2020-2034
- 11.4.1. Skincare Products
- 11.4.2. Wound Healing
- 11.4.3. Cancer Therapy
- 11.4.4. Autoimmune Disorders
- 11.4.5. Regenerative Medicine
- 11.4.6. Others
11.5. Market Value Forecast, by End-user, 2020-2034
- 11.5.1. Hospitals
- 11.5.2. Specialty Clinics
- 11.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Type of EGFs
- 11.7.2. By Application
- 11.7.3. By End-user
- 11.7.4. By Country/Sub-region

12. Asia Pacific Epidermal Growth Factors (EGFs) Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 12.3.1. TGF-alpha
- 12.3.2. Amphiregulin
- 12.3.3. Epiregulin
- 12.3.4. Betacellulin
- 12.3.5. Others
12.4. Market Value Forecast, by Application, 2020-2034
- 12.4.1. Skincare Products
- 12.4.2. Wound Healing
- 12.4.3. Cancer Therapy
- 12.4.4. Autoimmune Disorders
- 12.4.5. Regenerative Medicine
- 12.4.6. Others
12.5. Market Value Forecast, by End-user, 2020-2034
- 12.5.1. Hospitals
- 12.5.2. Specialty Clinics
- 12.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Type of EGFs
- 12.7.2. By Application
- 12.7.3. By End-user
- 12.7.4. By Country/Sub-region

13. Latin America Epidermal Growth Factors (EGFs) Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 13.3.1. TGF-alpha
- 13.3.2. Amphiregulin
- 13.3.3. Epiregulin
- 13.3.4. Betacellulin
- 13.3.5. Others
13.4. Market Value Forecast, by Application, 2020-2034
- 13.4.1. Skincare Products
- 13.4.2. Wound Healing
- 13.4.3. Cancer Therapy
- 13.4.4. Autoimmune Disorders
- 13.4.5. Regenerative Medicine
- 13.4.6. Others
13.5. Market Value Forecast, by End-user, 2020-2034
- 13.5.1. Hospitals
- 13.5.2. Specialty Clinics
- 13.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Type of EGFs
- 13.7.2. By Application
- 13.7.3. By End-user
- 13.7.4. By Country/Sub-region

14. Middle East & Africa Epidermal Growth Factors (EGFs) Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type of EGFs, 2020-2034
- 14.3.1. TGF-alpha
- 14.3.2. Amphiregulin
- 14.3.3. Epiregulin
- 14.3.4. Betacellulin
- 14.3.5. Others
14.4. Market Value Forecast, by Application, 2020-2034
- 14.4.1. Skincare Products
- 14.4.2. Wound Healing
- 14.4.3. Cancer Therapy
- 14.4.4. Autoimmune Disorders
- 14.4.5. Regenerative Medicine
- 14.4.6. Others
14.5. Market Value Forecast, by End-user, 2020-2034
- 14.5.1. Hospitals
- 14.5.2. Specialty Clinics
- 14.5.3. Others (Research Laboratories, Cosmetic Clinics, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Type of EGFs
- 14.7.2. By Application
- 14.7.3. By End-user
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
- 15.3.1. Johnson & Johnson
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. Amgen Inc.
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. Novartis AG
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. Merck & Co., Inc.
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. F. Hoffmann-La Roche AG
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. GSK plc
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. AstraZeneca plc
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. Bayer AG
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. AbbVie Inc.
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview

세계의 표피 성장 인자 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)

Epidermal Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

표피 성장 인자(EGFs) 시장 - 조사 범위

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약: 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : EGF유형별

제7장 세계 시장 분석과 예측 : 용도별

제8장 세계 시장 분석과 예측 : 최종 사용자별

제9장 세계 시장 분석과 예측 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

Epidermal Growth Factors (EGFs) Market - Scope of Report